Thoughts on practice and management of clinical research of traditional Chinese medicine during normalization stage of prevention and control of COVID⁃19
LING Li,LYU Xiang,SUN Yongning,et al.Thoughts on practice and management of clinical research of traditional Chinese medicine during normalization stage of prevention and control of COVID⁃19[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(10):4-7.
LING Li,LYU Xiang,SUN Yongning,et al.Thoughts on practice and management of clinical research of traditional Chinese medicine during normalization stage of prevention and control of COVID⁃19[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(10):4-7. DOI: 10.16305/j.1007-1334.2022.2205077.
Since the outbreak of novel coronavirus disease (COVID-19), traditional Chinese medicine (TCM) has been playing a unique role in the prevention and treatment of COVID-19. Meanwhile, the COVID-19 pandemic has brought opportunities and significant challenges to the TCM clinical research. By reviewing and analyzing the problems in the practice and management of TCM clinical research on COVID-19 during the normalization stage of pandemic prevention and control, we aim to explore and discuss the topic selection and project initiation, protocol design, ethical review, research implementation, and research management of TCM clinical research in this article, with a view to providing some suggestions for the scientific and standardized conduct of TCM clinical research on COVID-19 during the pandemic.
关键词
新型冠状病毒肺炎新型冠状病毒奥密克戎变异株中医药疗法临床研究疫情防控
Keywords
COVID-19SARS-CoV-2Omicron varianttraditional Chinese medicine therapyclinical researchpandemic prevention and control